Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles can assess carcinogen metabolism and imidazole compounds might be effective anticarcinogens.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Increased oxidative stress and decreased antioxidants contribute to hair loss in androgenetic alopecia.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Defective nuclear transport may cause gene expression changes in Progeria.

Proper cell death regulation is crucial for normal hair follicle regeneration and skin remodeling.

Temporary ROS production in cultured human hair follicles promotes growth and stem cell activation.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

EGFR inhibitors for lung cancer can cause severe skin issues.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Blocking cell death in hair follicles can lead to impaired hair growth.

Radiation affects plant growth differently, with high doses being harmful, but some lower doses can increase yield.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Copper and iron cause keratin damage in hair by converting methionine to homocysteine.

Gefitinib can cause rare scarring hair loss.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

The tested hair dye ingredients do not form harmful oxidized metabolites in the liver.

Some chemicals absorbed through the skin can cause serious health problems.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Wnt-activating drugs generally do not increase cancer risk.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Protecting hair and scalp from sunlight may help prevent hair loss.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.